pd 145065 has been researched along with Hypoxia in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Resta, TC; Walker, BR | 1 |
| Kanagy, NL; Nelin, LD; Walker, BR | 1 |
2 other study(ies) available for pd 145065 and Hypoxia
| Article | Year |
|---|---|
Chronic hypoxia selectively augments endothelium-dependent pulmonary arterial vasodilation.
Topics: 15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid; Animals; Biological Factors; Endothelins; Endothelium, Vascular; Histamine; Hypoxia; Ionomycin; Ionophores; Male; Muscle, Smooth, Vascular; Nitric Oxide; Oligopeptides; Prostaglandin Endoperoxides, Synthetic; Pulmonary Artery; Rats; Rats, Sprague-Dawley; Thromboxane A2; Vasoconstrictor Agents; Vasodilation | 1996 |
Role of endothelin in intermittent hypoxia-induced hypertension.
Topics: Air; Animals; Blood Pressure; Carbon Dioxide; Endothelin Receptor Antagonists; Endothelins; Heart Rate; Hypertension; Hypoxia; Male; Oligopeptides; Oxygen; Rats; Rats, Sprague-Dawley; Sleep Apnea Syndromes; Time Factors | 2001 |